Literature DB >> 12198178

Confirming specificity of RNAi in mammalian cells.

Patrice Lassus1, Joe Rodriguez, Yuri Lazebnik.   

Abstract

RNA interference (RNAi) is a process of sequence-specific gene silencing. Recent advances in the understanding of RNAi have provided practical tools to silence gene expression in mammalian cells, opening new possibilities for studying the functions of genes and proteins. It is important to ensure that an observed effect of RNAi is due to silencing of the intended target. Indeed, it is possible that an siRNA may silence more than one messenger RNA that is homologous in the region complementary to the siRNA. Considering that we know little about how RNAi works in mammalian cells, other artifacts may be yet to be recognized. Thus, we suggest approaches to rescue the effect of RNAi by ectopically expressing the protein of interest. These approaches involve introducing silent mutations into the complementary DNA of the protein and targeting RNAi to the untranslated regions of the gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198178     DOI: 10.1126/stke.2002.147.pl13

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  16 in total

1.  The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras.

Authors:  Qunyan Jin; Wei Ding; Kathleen M Mulder
Journal:  J Biol Chem       Date:  2012-05-27       Impact factor: 5.157

Review 2.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

Review 3.  Exploring biology with small organic molecules.

Authors:  Brent R Stockwell
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

4.  Investigation of RNA interference to suppress expression of full-length and fragment human huntingtin.

Authors:  Devin S Gary; Abigail Davidson; Olivier Milhavet; Hilda Slunt; David R Borchelt
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

5.  Attenuated protein expression vectors for use in siRNA rescue experiments.

Authors:  Eiji Morita; Jun Arii; Devin Christensen; Jörg Votteler; Wesley I Sundquist
Journal:  Biotechniques       Date:  2012-08       Impact factor: 1.993

6.  Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.

Authors:  Bingshe Han; Dongkyoo Park; Rui Li; Maohua Xie; Taofeek K Owonikoko; Guojing Zhang; Gabriel L Sica; Chunyong Ding; Jia Zhou; Andrew T Magis; Zhuo G Chen; Dong M Shin; Suresh S Ramalingam; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Cell       Date:  2015-05-21       Impact factor: 31.743

7.  Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi.

Authors:  Benoit Bilanges; David Stokoe
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

8.  RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.

Authors:  Mario Bunse; Gavin M Bendle; Carsten Linnemann; Laura Bies; Stephan Schulz; Ton N Schumacher; Wolfgang Uckert
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

Review 9.  On future's doorstep: RNA interference and the pharmacopeia of tomorrow.

Authors:  Alan M Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation.

Authors:  B Nelson Chau; Tung-Ti Chen; Yisong Y Wan; James DeGregori; Jean Y J Wang
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.